Australia's most trusted
source of pharma news
Monday, 18 May 2026
Posted 18 May 2025 AM
A “consortium of the willing” will meet in July to improve the design and delivery of oncology clinical trials for Australian patients.
“Only between five and six per cent of patients with cancer in Australia go on to a clinical trial, despite the fact that, regardless of what drug you end up on, the outcomes of being on a clinical trial are so much higher than not,” Edge Medical Solutions Medical Director Matt Britland said.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.